Skip to content Skip to menu

Appointment of Medicines Australia Board of Directors and interim-Chairman

Tuesday, 20 October 2015

Media Release

Mr Wes Cook, Managing Director of Boehringer Ingelheim Australia, has been selected as the interim-Chairman of Medicines Australia.

The appointment was made at the first meeting of the new Board of Directors following the Medicines Australia Annual General Meeting in Sydney today.

The decision to appoint a temporary Chairman follows the retirement of Dr Martin Cross and will allow the Board to conduct a thorough process to appoint a permanent replacement.

Medicines Australia CEO Tim James said, “Wes is a well-known member of the innovative medicines industry and has been a Board Member of Medicines Australia since 2012. As interim-Chairman, Wes will continue to be a strong, effective advocate for our members and the industry.”

“I would also like to congratulate all Medicines Australia Board Members who were selected following the recently conducted members ballot.”

The new Board was also announced at today’s Annual General Meeting and will serve until October 2017.

Board of Medicines Australia 2015-2017
Wes Cook (Boehringer Ingelheim) James Jones (Takeda)
Brad Edwards (Shire) Geoff McDonald (GSK)
Dr Susanne Fiedler (MSD) Kirsten O’Doherty (AbbVie)
David Gallagher (Pfizer) Svend Petersen (Roche)
Brian Gladsden (Novartis) James Priour (Amgen)
Chris Hourigan (Janssen)  Paul Spittle (AstraZeneca)

“On behalf of Medicines Australia, I would like thank all outgoing Board members, and particularly Dr Martin Cross, for their selfless service to the industry during their time as Directors and congratulate all members of the new Board on their nominations,” said Mr James.

“This is an exciting and important time for Medicines Australia, its members and the wider industry. There will be many opportunities and challenges ahead and I am confident that the Board will offer strong guidance and insight during their term,” said Mr James.

“I look forward to working closely with the Board and all of our members in the weeks and months ahead.”

Contact:

James Boyce
Phone: 0423 239 265
Email:
James.Boyce@medicinesaustralia.com.au

Top